About Arpeggio Biosciences
Arpeggio Biosciences is a private company based in Boulder, Colorado. It has reported $46,407,383 raised in five offerings on Form D since August 2019. Its chief executive is Joseph Azofeifa.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Nov 24, 2025 | $20,037,075of $35.3M target | 12 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Mar 19, 2025 | Mar 27, 2025 | $4,026,774of $4.5M target | 14 | $287K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 3, 2022 | Sep 23, 2022 | $20,248,534of $20.2M target | 28 | $723K | EquityRule 506(b) | Form D ↗ |
| Aug 22, 2019 | Sep 6, 2019 | $1,970,000of $3.0M target | 5 | $394K | Options, Securities on exercise, Simple Agreement for Future Equity that is convertible into equity securities of the Issuer.Rule 506(b) | Form D ↗ |
| Aug 16, 2019 | Aug 29, 2019 | $125,000of $500K target | 1 | $125K | Options, Securities on exercise, Simple Agreement for Future Equity that is convertible into equity securities of the Issuer.Rule 506(b) | Form D ↗ |
| Total, five offerings | $46,407,383 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Arpeggio Biosciences's Form D filed Nov 24, 2025.
TR
Timothy Read
Executive officer
LN
Laura Norris
Executive officer
DA
David Allison
Director
JA
Joseph Azofeifa
President and CEO, director
MC
Mira Chaurushiya
Director
SK
Samuel Kintz
Director
AR
Aaron Royston
Director
Earlier filings also listed Amit Mehta (director, last listed Mar 2025), Eric Martin (executive officer, last listed Sep 2022), Robin Dowell-Deen (promoter, last listed Sep 2019), Joe McMahon (director, last listed Sep 2019) and Daniel Weaver (promoter, last listed Sep 2019).